Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
initial US approval 2022, paediatric T2D label updateTier 1 primary [3]NICE TA924: tirzepatide for treating type 2 diabetes (published 25 October 2023, updated 1 September 2025)Tier 1 primary [4]NICE TA1026: tirzepatide for managing overweight and obesity (published 23 December 2024, updated 1 September 2025)Tier 1 primary [5]Jastreboff et al
Disruption of SUMOylation has been implicated in AD, HD and PD, where it contributes to protein aggregation, synaptic dysfunction, and neuronal vulnerability
Minimize the time it spends at room temperature
It slows stomach emptying
Semaglutide is the active ingredient in popular brand-name medications like Ozempic and Wegovy, used for Type 2 Diabetes and chronic weight management
The glucagon-receptor activity is the part that makes retatrutide pharmacologically distinct
